MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
Public ClinicalTrials.gov record NCT05090566. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1B/2, OPEN LABEL UMBRELLA STUDY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA) CD3 BISPECIFIC ANTIBODY, IN COMBINATION WITH OTHER ANTI-CANCER TREATMENTS IN PARTICIPANTS WITH MULTIPLE MYELOMA
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the Recommended Phase 2 Dose and clinical benefit of elranatamab in combination with other anti-cancer therapies in participants with multiple myeloma.
Study identification
- NCT ID
- NCT05090566
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2021 (Actual)
- Primary completion
- Feb 13, 2025 (Actual)
- Completion
- Mar 11, 2026 (Actual)
- Last update posted
- Apr 24, 2026
2021 – 2026
United States locations
- U.S. sites
- 22
- U.S. states
- 5
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Gateway Medical Center | Gilbert | Arizona | 85234 | — |
| Banner Gateway Medical Pavilion | Gilbert | Arizona | 85234 | — |
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Banner Health d.b.a. Banner MD Anderson Cancer Center | Phoenix | Arizona | 85012 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Clinical Research Advisors | Encino | California | 91316 | — |
| Clinical Research Advisors | Los Angeles | California | 90020 | — |
| Cedars Sinai Medical Center Oncology IDS Pharmacy Attn:Suwicha Limvorasak ,PharmaD | Los Angeles | California | 90048 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI) | Los Angeles | California | 90048 | — |
| Clinical Research Advisors | Los Angeles | California | 90048 | — |
| Cedars-Sinai Tarzana | Tarzana | California | 91356 | — |
| Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center | Coral Gables | Florida | 33146 | — |
| University of Miami | Coral Gables | Florida | 33146 | — |
| Sylvester Comprehensive Cancer Center- Deerfield Beach | Deerfield Beach | Florida | 33442 | — |
| Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| UHealth Tower | Miami | Florida | 33136 | — |
| The Johns Hopkins University School of Medicine | Baltimore | Maryland | 21205 | — |
| OIDS, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21231 | — |
| The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Also Imaging Facility) | Baltimore | Maryland | 21231 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05090566, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05090566 live on ClinicalTrials.gov.